MAPT and Alzheimer disease: Some medical studies have demonstrated an association between cerebrospinal fluid tau protein levels (CSF-tau) and the severity of AD (Braak et al. 2011, Jack Jr et al. 2018, Shaw et al. 2018, Mummery et al. 2023).